Underlying disease for percutaneous endoscopic gastrostomy tube placement predicts short- and long-term mortality.

Bochatay, L; Bastid, C; Robert, J; Giostra, E; Spahr, L; Bichard, P; Frossard, J L

Bochatay, L; Bastid, C; Robert, J; Giostra, E; Spahr, L; Bichard, P; Frossard, J L.

Affiliation

Bochatay L; Department of Gastroenterology and Hepatology, University Hospital of Geneva, Switzerland.
Bastid C; Service of Gastroenterology, Hospital de Nyon, Groupement Hospitalier de l'Ouest Lémanique (GHOL), Switzerland.
Robert J; Department of Gastroenterology and Hepatology, University Hospital of Geneva, Switzerland.
Giostra E; Department of Gastroenterology and Hepatology, University Hospital of Geneva, Switzerland.
Spahr L; Department of Gastroenterology and Hepatology, University Hospital of Geneva, Switzerland.
Bichard P; Department of Gastroenterology and Hepatology, University Hospital of Geneva, Switzerland.
Frossard JL; Department of Gastroenterology and Hepatology, University Hospital of Geneva, Switzerland.

Acta Gastroenterol Belg ; 85(1): 29-33, 2022.

Article de En | MEDLINE | ID: mdl-35304991

Sujet(s)
Mots clés

Percutaneous endoscopic gastrostomy (PEG); indication; mortality; palliative procedure; prognosis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Gastrostomie / Troubles de la déglutition Type d'étude: Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Acta Gastroenterol Belg Année: 2022 Type de document: Article Pays d'affiliation: Suisse Pays de publication: Belgique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google